ASH 23
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
ASH 23
Dec 23, 2023, 03:36 |
Blog
Vincent Rajkumar: Updated treatment approach to newly diagnosed myeloma based on new ASH 23 data
Vincent Rajkumar, Editor-in-Chief at Blood Cancer Journal, recently posted on X/Twitter: “Updated treatment approach to…
Dec 16, 2023, 17:43 |
Blog
Layla Doren: Systemic racism in healthcare
Layla Doren, Assistant Professor of Medicine at Yale New Haven Hospital, shared on X/Twitter: “2.6…
Dec 12, 2023, 18:37 |
Blog
Klaus Metzeler: Some of my (secret) favourites in the AML/MDS field
Klaus Metzeler, Professor of Translational Haematology at University of Leipzig, shared on X/Twitter: “As the ASH 23…
Dec 12, 2023, 18:26 |
Blog
Talha Badar: Our abstract studying immune clustering via CyTOF in AML pts receiving VEN+HMA
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter:…
Dec 11, 2023, 18:18 |
Blog
Vinay Prasad: This is a great metaphor for the role of professional societies in driving progress
Vinay Prasad, Professor in the Department of Epidemiology and Biostatistics at the University of California…
Dec 9, 2023, 17:09 |
Blog
Naveen Pemmaraju: Honored to spend some great quality time with Richard Silver this evening at MPN Hero 2023
Naveen Pemmaraju, made the following post on X/Twitter: “ASH 23 Wow! What an evening. Honored…
Dec 9, 2023, 16:52 |
Blog
Navneet Majhail: We are hiring transplant/cellular therapy/leukemia physicians at HCA Healthcare and Sarah Cannon
Navneet Majhail, Physician-in-Chief of Blood Cancers at Sarah Cannon Research Institute, shared a post on…
Dec 9, 2023, 11:52 |
Blog
Shernan Holtan: It's hematologists pumping iron time
Shernan Holtan, Chief of the Blood and Marrow Transplant Program at Roswell Park, shared on X/Twitter:…
All:
8
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube